Alnylam Pharmace. buy kyron7htx
Start price
05.02.19
/
50%
€76.96
Target price
07.02.19
€108.24
Performance (%)
-5.47%
End price
07.02.19
€72.75
Summary
This prediction ended on 07.02.19 with a price of €72.75. With a performance of -5.47%, the BUY prediction by kyron7htx finished with a loss. kyron7htx has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alnylam Pharmace. | 4.797% | 4.797% | -3.119% | 45.158% |
| iShares Core DAX® | -2.195% | 0.670% | 0.546% | 51.111% |
| iShares Nasdaq 100 | -2.629% | 2.992% | 34.108% | 91.988% |
| iShares Nikkei 225® | -2.021% | 3.141% | 53.424% | 65.852% |
| iShares S&P 500 | -1.670% | 2.405% | 23.220% | 66.636% |
Comments by kyron7htx for this prediction
In the thread Alnylam Pharmace. diskutieren
(Stop Loss Kurs erreicht)
Stopped prediction by kyron7htx for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€69.33
08.02.19
08.02.19
€108.24
04.11.21
04.11.21
116.51%
17.07.21
17.07.21
